Public Health Trumps User Fee Goals, FDA Leaders Say – But That May Be Good News For Sponsors

FDA wants to be judged on its overall impact on public health - not on drug approvals - Commissioner Margaret Hamburg and Principal Deputy Joshua Sharfstein say in an 1editorial published in the New England Journal of Medicine May 26